Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment

Kashi Raj Bhattarai(Pharmaceutical Biotechnology (Czechia)), Daniel Savic(St. Jude Children's Research Hospital)
medRxiv
February 11, 2023
10.1101/2023.02.10.23285762
Cited by 0

Related Papers

Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia
|Nature Communications|2022|27
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators
|Cell Genomics|2023|14
Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicin
|Blood|2025|5